Texas Instruments and IIT Kharagpur to collaborate on breakthrough medical technology research

Tuesday, April 1, 2008 General News
Email Print This Page Comment bookmark
Font : A-A+

KOLKATA, India, April 1 Texas Instruments Incorporated(TI) (NYSE: TXN) has signed a collaborative agreement with the School ofMedical Science and Technology (SMST), Indian Institute of Technology (IIT)Kharagpur, to develop semiconductor technologies that will help improve thequality, comfort and accessibility of health care.

This is the first time that TI has partnered with any IIT in India onresearch projects devoted to medical electronics innovation. The announcementwas made here today by Dr. Biswadip (Bobby) Mitra, managing director, TexasInstruments India, and Professor Ajoy Kumar Ray, head - SMST, IIT Kharagpur.

TI works with medical device customers across the globe to make qualityhealth care more accessible to more people. In September 2007, the companyannounced that it would invest a total of $15 million to fund medicaltechnology research at selected universities worldwide with a focus on quality,accessibility and affordability. TI's goal in supporting this research is tohelp develop new semiconductor technologies for personal medical devices,implantables, medical imaging, wireless healthcare systems and bio-sensortechnology. The TI-IIT Kharagpur research collaboration is a part of thiseffort.

The collaboration also reflects TI's commitment to engineering educationand developing the next generation of innovators. The research projects TI isfunding at IIT Kharagpur will be undertaken by students holding B. Tech, M.Tech, M. Stats or M. Sc (Physics or Mathematics) degrees with specializationsin image processing, neural networks and pattern recognition, digital signalprocessor-based embedded system design, and MEMS-based bio-sensors. Thesestudents, to be selected by IIT Kharagpur, will register for a MS/PhD programunder the TI-SMST Research Scheme.

"Together, TI and IIT Kharagpur have the opportunity to help improve thequality of life for millions of people around the world," said Mitra. "InIndia alone, about 800,000 patients undergo coronary bypass surgery everyyear; one in every 12 women develops breast cancer. Also, oral leukoplakiaand oral sub-mucous fibrosis have been widely prevalent in India and a causefor concern to scientists in the country. The TI-IIT Kharagpur technologypartnership will enable devices that could help address some of these pressinghealthcare issues."

Kent Novak, vice president and manager of TI's Medical andHigh-Reliability business unit said, "All of us at TI are excited about thispartnership with IIT Kharagpur, which has the research capabilities,commitment, enthusiasm and insight to help us develop semiconductortechnologies that will make a difference in the medical area. With ourexpertise in analog and digital signal processing and the university'sresearch strength and ability to bring together and develop new ideas, thiswill be a powerful partnership."

"The Advanced Technology Center in IIT Kharagpur is equipped with basicfacilities and infrastructure for undertaking research projects insilicon-based microelectronics," said Ray. "We are excited about thisassociation with TI, a company globally acknowledged for its strides insemiconductor research and development, and we are confident that thispartnership is an important step toward developing solutions to help peoplewith cancer and heart ailments in this country."

About Texas Instruments:

Texas Instruments (NYSE: TXN) helps customers solve problems and developnew electronics that make the world smarter, healthier, safer, greener andmore fun. A global semiconductor company, TI innovates through manufacturing,design and sales operations in more than 25 countries. For more information,go to http://www.ti.com.

About SMST, IIT Kharagpur:

The Indian Institute of Technology, Kharagpur, in the year of its GoldenJubilee, in 2001 established the School of Medical Science & Technology. Thisis

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store